Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Apr 8, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application for...
-
Mar 30, 2015- Advances Perrigo's stated strategy to expand internationally and leverage the combined product portfolio of Perrigo and Omega
Perrigo Company plc (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced that it has completed the acquisition of Belgian-based Omega Pharma...
-
Mar 4, 2015
Booth No. 2615 -- Perrigo Animal Health, a division of Perrigo Company plc (NYSE: PRGO; TASE), showcased two new product lines at the 2015 Global Pet Expo: SENTRY® Fiproguard® Plus and SENTRY®...
-
Mar 4, 2015Booth No. 2601
Perrigo Animal Health, a division of Perrigo Company plc (NYSE: PRGO); (TASE: PRGO), showcased two new product lines at the 2015 Global Pet Expo: PetArmor® Plus and PetArmor® Soft & Chewy...
-
Mar 4, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the 2015 Barclays Global Healthcare Conference at 8:00AM ET on...
-
Feb 17, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the 2015 RBC Global Healthcare Conference at 4:35PM EST on Tuesday,...
-
Feb 5, 2015
Fiscal second quarter net sales increased to a second quarter record of $1.07 billion. Excluding the effect of the pre-closing debt and equity issuances related to the previously announced...
-
Jan 29, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its second quarter fiscal year 2015 on Thursday, February 5, 2015 at approximately 7:30 a.m. (ET)....
-
Jan 27, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that its Board of Directors declared a quarterly dividend of $0.125 per share, payable on March 17, 2015 to shareholders of record on...
-
Jan 22, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its second quarter fiscal year 2015 on Thursday, February 5, 2015 at approximately 8:00 a.m. (ET)....
-
Jan 12, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has launched its AB therapeutic equivalent testosterone gel 1.0%. The Food and Drug Administration (FDA) concluded previously that...
-
Jan 12, 2015
Perrigo Company plc (NYSE: PRGO; TASE), and Ferrara Candy Company, Inc. ("Ferrara"), announced today that Perrigo's Nutritionals division has signed a supply agreement with Ferrara to manufacture...
-
Jan 12, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has launched clobetasol propionate spray, 0.05%, the generic equivalent to Clobex® Spray, 0.05%. Perrigo was the first generic filer...
-
Jan 6, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, January...
-
Dec 2, 2014
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced the closing of the previously announced registered...
-
Dec 2, 2014
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for...
-
Nov 26, 2014
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced the closing of Perrigo's previously announced...
-
Nov 24, 2014
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced the pricing of the registered public offering by...
-
Nov 24, 2014
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced that the underwriters for Perrigo's previously...
-
Nov 24, 2014
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced that Perrigo Finance plc, a finance subsidiary of...
-
Nov 24, 2014
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application for testosterone undecanoate injection...
-
Nov 24, 2014
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has agreed to market the authorized generic version of Astellas U.S. LLC's' Protopic® Ointment 0.1% and 0.03%. Shipments to our...
-
Nov 20, 2014
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced the pricing of the registered public offering of...
-
Nov 20, 2014
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced that it is commencing a registered public offering of...
-
Nov 6, 2014
Perrigo Company plc (NYSE: PRGO; TASE) announced today that it has reinitiated shipments of Guaifenesin 600mg Extended-Release tablets to its retail and wholesale customers in the United States....